Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Santus

Showing results (11-20 of 53) with videos related to

Pageof 6
Sort By:
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|January 5, 2002
Atopy prevalence and spirometric performance in asymptomatic schoolchildren exposed to air pollutionS Centanni, F Di Marco, F Castagna, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 5, 2001
The potential role of tocopherol in asthma and allergies: modification of the leukotriene pathwayS Centanni, P Santus, F Di Marco, et al.
La Nouvelle Presse Medicale|November 13, 1982
[Postoperative cholecystitis associated with gallbladder candidiasis]J P Santus, A Edouard, A Vivien, et al.
La Nouvelle Presse Medicale|January 20, 1979
[Thyroid carcinoma. Indications and results of treatment (author's transl)]J Reynier, G Vallée, J G Brun, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|June 16, 2009
Stromelysin-1 polymorphism as a new potential risk factor in progression of chronic obstructive pulmonary diseaseP Santus, F Casanova, M L Biondi, et al.
European Journal of Internal Medicine|June 8, 2015
Why use long acting bronchodilators in chronic obstructive lung diseases? An extensive review on formoterol and salmeterolP Santus, D Radovanovic, P Paggiaro, et al.
Expert Opinion on Pharmacotherapy|October 13, 2005
Azithromycin and lower respiratory tract infectionsF Blasi, M Cazzola, P Tarsia, et al.
Drugs Under Experimental and Clinical Research|December 8, 2000
Evaluation of the effects of zafirlukast 40 mg b.i.d. in addition to preexisting therapy of high-dose inhaled steroids on symptomatic patients with reversible respiratory obstruction: preliminary dataS Centanni, P Santus, F Casanova, et al.
Minerva Medica|December 12, 2013
COPD classification methods and informativeness on mortality: contrasting evidencesF Braido, F DI Marco, P Santus, et al.
European Review for Medical and Pharmacological Sciences|December 2, 2022
Oxidative stress and viral Infections: rationale, experiences, and perspectives on N-acetylcysteineP Santus, F Danzo, A Zuffi, et al.
Pageof 6

Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|January 5, 2002
Atopy prevalence and spirometric performance in asymptomatic schoolchildren exposed to air pollutionS Centanni, F Di Marco, F Castagna, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 5, 2001
The potential role of tocopherol in asthma and allergies: modification of the leukotriene pathwayS Centanni, P Santus, F Di Marco, et al.
La Nouvelle Presse Medicale|November 13, 1982
[Postoperative cholecystitis associated with gallbladder candidiasis]J P Santus, A Edouard, A Vivien, et al.
La Nouvelle Presse Medicale|January 20, 1979
[Thyroid carcinoma. Indications and results of treatment (author's transl)]J Reynier, G Vallée, J G Brun, et al.
Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace|June 16, 2009
Stromelysin-1 polymorphism as a new potential risk factor in progression of chronic obstructive pulmonary diseaseP Santus, F Casanova, M L Biondi, et al.
European Journal of Internal Medicine|June 8, 2015
Why use long acting bronchodilators in chronic obstructive lung diseases? An extensive review on formoterol and salmeterolP Santus, D Radovanovic, P Paggiaro, et al.
Expert Opinion on Pharmacotherapy|October 13, 2005
Azithromycin and lower respiratory tract infectionsF Blasi, M Cazzola, P Tarsia, et al.
Drugs Under Experimental and Clinical Research|December 8, 2000
Evaluation of the effects of zafirlukast 40 mg b.i.d. in addition to preexisting therapy of high-dose inhaled steroids on symptomatic patients with reversible respiratory obstruction: preliminary dataS Centanni, P Santus, F Casanova, et al.
Minerva Medica|December 12, 2013
COPD classification methods and informativeness on mortality: contrasting evidencesF Braido, F DI Marco, P Santus, et al.
European Review for Medical and Pharmacological Sciences|December 2, 2022
Oxidative stress and viral Infections: rationale, experiences, and perspectives on N-acetylcysteineP Santus, F Danzo, A Zuffi, et al.
Pageof 6